Clinical Trials Directory

Trials / Conditions / Gastro-esophageal Junction Cancer

Gastro-esophageal Junction Cancer

13 registered clinical trials studyying Gastro-esophageal Junction Cancer — 3 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingEPITOME-1015-I: a Study to Investigate the Safety and Tolerability of MDG1015 in Patients with Epithelial Ovar
NCT06748872
Medigene AGPhase 1
Not Yet RecruitingPerioperative Surufatinib Plus Sintilimab Combined With Chemotherapy in Gastric/Gastroesophageal Junction Aden
NCT06447636
Fudan UniversityPhase 2
SuspendedPreoperative HFRT Verses PULSAR for Locally Advanced GEJ or Proximal Gastric Adenocarcinoma
NCT06728657
Fudan UniversityPhase 2
RecruitingStudy of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
NCT06005493
AstraZenecaPhase 1 / Phase 2
UnknownInvestigator-initiated Pilot Study to Investigate the Efficacy and Safety of Immuncell-LC in Combination With
NCT05053295
Gangnam Severance HospitalN/A
Active Not RecruitingPerioperative mFOLFOX Plus Pembrolizumab in Gastroesophageal Junction (GEJ) and Stomach Adenocarcinoma
NCT03488667
University of Kansas Medical CenterPhase 2
Active Not RecruitingNeoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer
NCT03448835
The Netherlands Cancer InstitutePhase 2
CompletedPReoperative Chemoradiation (Paclitaxel-carboplatin or FOLFOX) for Resectable Esophageal and Junctional Cancer
NCT02359968
Centre Oscar LambretPhase 2
CompletedPhase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
NCT01084330
Novartis PharmaceuticalsPhase 2
UnknownQuality of Life With Esophageal Stent Trial
NCT01044511
Michael Bau MortensenN/A
CompletedChemoradiation and Panitumumab for Esophageal Cancer
NCT01077999
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Phase 2
CompletedIncidence and Patterns of Nausea/Vomiting With Combined Chemotherapy and Radiation
NCT00716157
Thomas Jefferson University—
CompletedAdjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma
NCT00215514
Dana-Farber Cancer InstituteEARLY_Phase 1